Announcement from FRISQ's annual general meeting

The annual general meeting ("AGM") of Frisq Holding AB ("FRISQ" or the "Company") was held today on 4 June 2019 and the following resolutions were passed by the meeting.

Adoption of the income statement and the balance sheet
The AGM resolved to adopt the income statement and the balance sheet in FRISQ and the consolidated income statement and the consolidated balance sheet.

Allocation of profit
The AGM resolved that no dividend would be paid to the shareholders and that the previously accrued results would be carried forward.

Discharge from liability
The board of directors and the CEO were discharged from liability for the financial year 2018.

Election of the board of directors, auditor and remuneration
The AGM resolved that the board of directors shall comprise six directors and no deputy directors. The AGM resolved that the number of auditors shall be one registered audit firm.

It was further resolved that the remuneration is to be SEK 700,000 in total, (SEK 700,000 previous year), and shall be paid to the directors in the following amounts:

  • SEK 100,000 (SEK 100,000) for each of the non-employed directors and SEK 200,000 (SEK 200,000) to the chairman.

It was further resolved that remuneration to the auditor shall be paid in accordance with approved invoices.

Lars Björk, Anna Frick, Åke Hallman, Göran Hägglund, Per-Egon Johansson and Mats Lindstrand were re-elected as directors of the board. Mats Lindstrand was re-elected as chairman of the board.

MAZARS SET Revisionsbyrå AB was re-elected as the Company auditor. MAZARS SET Revisionsbyrå AB has announced that Samuel Bjälkemo will continue to act as main responsible auditor.

Authorization for the board to issue shares, convertibles and/or warrants
The AGM resolved, in accordance with the board of directors' proposal, to authorize the board, on one or more occasions, with or without preferential rights for shareholders, to issue in total a maximum of shares, warrants and/or convertibles, with the right to subscribe and convert to ordinary shares, respectively, in the Company, corresponding to not more than 20 percent of the share capital of the Company after completed issuances based on the number of shares at the time of the annual general meeting, to be paid in cash, by set-off or in-kind.

The reason for the authorization and deviation from the shareholders' preferential rights is to enable raising capital for expansion through acquisitions of companies or assets and for the business of the Company as well as to adapt the Company's capital and/or ownership structure. If issuances are carried out with deviation from the shareholders' preferential rights such issue shall be made in accordance with customary market terms.

For further details regarding the resolutions set out above refer to the notice and annual accounts available at the Company's website, www.frisqholding.se.

For further information:
Martin Irding, CEO FRISQ
Tel: +46 (0)8 120 131 21
E-mail: martin.irding@frisq.se

About FRISQ
The healttech company FRISQ develops global scalable digital tools for interactive communication between the different parties in the healthcare chain.

Since 2016, the company has been listed on Nasdaq First North in Stockholm under the short name "FRISQ".
FNCA Sweden AB is FRISQ's Certified Adviser. Tel +46 (0)8 528 00 399, info@fnca.se
For more information, please visit www.frisqholding.se.

About Us

Om FRISQFRISQ utvecklar digitala tjänster för att förbättra informations- och kommunikationsflödet mellan privatpersoner, apotek, vård och omsorg. Vårt mål är att utveckla innovativa verktyg och förbättra tillgången till hälso- och sjukvårdsinformation så att individer kan ta kontroll över sin egen hälsa.

Subscribe

Documents & Links